Advertisement
Home Tags Cancer: Misc.

Tag: Cancer: Misc.

Financial toxicity is a clinically relevant outcome for patients receiving treatment for advanced cancer

Financial Toxicity Is a Relevant Cancer Outcome Measure

0
Health-related quality of life correlated with financial toxicity in cancer patients
Lartruvo (olaratumab) has been approved by the U.S. Food and Drug Administration to treat adults with certain soft tissue sarcomas.

FDA Approves New Treatment for Advanced Soft Tissue Sarcoma

0
Sanctioned for use with doxorubicin in cases that cannot be treated with radiation or surgery
For patients with advanced retinoblastoma

Topotecan-Based Therapy Beneficial for Retinoblastoma

0
Findings show globe salvage with vision for topotecan plus vincristine, carboplatin, focal therapy
Obesity before a cancer diagnosis is associated with an increased risk for overall and individual secondary primary cancers in males

Obesity Ups Risk for Secondary Primary Cancers in Men

0
Higher risk of secondary primary cancer in obese male survivors versus general population
After adjusting for inflation

Price Increases Larger for Older Cancer Drugs Than Newer Ones

0
Older meds rose 22.7 percent in price, compared to a 6.2 percent increase for newer treatments
Statin therapy is associated with reduced risk of all-cause and multiple myeloma-specific mortality

Statins Reduce Risk of Mortality in Multiple Myeloma

0
Reduced risk of both all-cause and multiple myeloma-specific mortality in cohort of veterans

American Society for Radiation Oncology, Sept. 25-28

0
The 58th Annual Meeting of the American Society for Radiation Oncology The annual meeting of the American Society for Radiation Oncology was held...
Many cancer patients hold unrealistic hopes when they decide to join early-stage clinical trials of experimental treatments

Cancer Patients Have Unrealistic Hopes Entering Clinical Trials

0
Study finding is a red flag, researcher says
In germ cell tumors

TP53, MDM2 Alterations Linked to Cisplatin Resistance in GCT

0
TP53, MDM2 alterations predict adverse prognosis in patients with germ cell tumors
More Americans are benefiting from immunotherapy

AACR: More Cancer Patients Benefiting From Immunotherapy

0
Therapies help arm the body to fight off malignancy, according to Cancer Progress Report